ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 223 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $585,367 | +102596.0% | 66,293 | -11.2% | 0.02% | 0.0% |
| Q4 2022 | $570 | -99.9% | 74,655 | +19.1% | 0.02% | +14.3% |
| Q3 2022 | $446,000 | +26.3% | 62,701 | +43.6% | 0.01% | +40.0% |
| Q2 2022 | $353,000 | +8.6% | 43,669 | +86.5% | 0.01% | +25.0% |
| Q1 2022 | $325,000 | -27.8% | 23,412 | +45.9% | 0.01% | -27.3% |
| Q4 2021 | $450,000 | -50.8% | 16,042 | -40.4% | 0.01% | -47.6% |
| Q3 2021 | $915,000 | -15.5% | 26,921 | +1.5% | 0.02% | -12.5% |
| Q2 2021 | $1,083,000 | +30.6% | 26,514 | +28.8% | 0.02% | +26.3% |
| Q1 2021 | $829,000 | -15.1% | 20,583 | +24.6% | 0.02% | -5.0% |
| Q4 2020 | $977,000 | +71.1% | 16,524 | +40.8% | 0.02% | +53.8% |
| Q3 2020 | $571,000 | – | 11,737 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
| Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
| Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
| Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
| TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
| Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
| Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
| Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
| Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |